Multimorbidity: Not Just for the West
References
- Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997; 349: 1269–76. DOI: 10.1016/S0140-6736(96)07493-4
- Hurst JR, Dickhaus J, Maulik PK, et al. Global Alliance for Chronic Disease researchers’ statement on multimorbidity. Lancet Glob Health. 2018; 6: e1270–1. DOI: 10.1016/S2214-109X(18)30391-7
- Academy of Medical Sciences.
Multimorbidity: A priority for global health research . London: Academy of Medical Sciences, 2018.https://acmedsci.ac.uk/policy/policy-projects/multimorbidity . - Whitty CJM, Watt FM. Map clusters of diseases to tackle multimorbidity. Nature. 2020; 579(7800): 494–496.
https://www.nature.com/articles/d41586-020-00837-4 . DOI: 10.1038/d41586-020-00837-4 - Montori VM, Gandhi GY, Guyatt GH. Patient-important outcomes in diabetes--time for consensus. Lancet. 2007; 370: 1104–6. DOI: 10.1016/S0140-6736(07)61489-5
- Dobler CC, Harb N, Maguire CA, Armour CL, Coleman C, Murad MH. Treatment burden should be included in clinical practice guidelines. BMJ. 2018; 363: k4065. DOI: 10.1136/bmj.k4065
- World Health Organization.
Global strategy on human resources for health: workforce 2030 . Geneva: World Health Organization; 2016.https://apps.who.int/iris/bitstream/10665/250368/1/9789241511131-eng.pdf?ua=1 . - Accelerating progress towards Universal Health Coverage. UHC2030.
https://www.uhc2030.org/ (Accessed 19 October 2019). - National Institute for Health and Care Excellence (NICE). Multimorbidity: clinical assessment and management. NICE guideline [NG56]. NICE.
https://www.nice.org.uk/guidance/ng56 (accessed 15 September 2017). - Mounier-Jack S, Mayhew SH, Mays N. Integrated care: learning between high-income, and low- and middle-income country health systems. Health Policy Plan. 2017; 32: iv6–12. DOI: 10.1093/heapol/czx039
- Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, Liu XQ, Chen RC, Tang CL, Wang T, Ou CQ, Li L, Chen PY, Sang L, Wang W, Li JF, Li CC, Ou LM, Cheng B, Xiong S, Ni ZY, Xiang J, Hu Y, Liu L, Shan H, Lei CL, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Cheng LL, Ye F, Li SY, Zheng JP, Zhang NF, Zhong NS, He JX, China Medical Treatment Expert Group for Covid-19. Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. European Respiratory Journal. 2020. DOI: 10.1183/13993003.00547-2020
- Moore GF, Audrey S, Barker M, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015; 350: h1258. DOI: 10.1136/bmj.h1258
DOI: https://doi.org/10.5334/gh.835 | Journal eISSN: 2211-8179
Language: English
Submitted on: May 30, 2020
Accepted on: Jun 12, 2020
Published on: Jul 2, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2020 Amitava Banerjee, John Hurst, Edward Fottrell, J. Jaime Miranda, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.